Autoimmune Skin Diseases In The Era Of COVID-19: Pathophysiological Insights And Clinical Implications

    September 2025 in “ Microorganisms
    Aikaterini Ι. Liakou, Eleni Routsi, Kalliopi Plisioti, Eleni Tziona, Dimitra Koumaki, Magdalini Kalamata, Evangelia‐Konstantina Bompou, Rozeta Sokou, Πέτρος Ιωάννου, Stefanos Bonovas, George Samonis, Andreas G. Tsantes, Alexander J. Stratigos
    New to Alopecia Areata? There is a guide in the encyclopedia. Read the guide →
    Studysummary In this review, the authors explore the complex interplay between COVID-19 and autoimmune skin diseases, finding that SARS-CoV-2 may trigger or worsen these conditions, with increased risks following infection and vaccination, particularly with mRNA vaccines.
    Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
    The document reviews the complex relationship between COVID-19 and autoimmune skin diseases (ASDs), such as alopecia areata, psoriasis, and hidradenitis suppurativa, highlighting that SARS-CoV-2 can trigger or exacerbate these conditions through mechanisms like immune dysregulation and cytokine signaling. Epidemiological data indicate increased incidence and flares of ASDs post-COVID-19 infection and vaccination, with mRNA vaccines posing a higher risk for hidradenitis suppurativa flares. Despite initial concerns, biologic therapies for psoriasis and HS do not appear to increase COVID-19 severity. The review underscores the importance of continued research to understand these interactions and improve patient management, emphasizing individualized vaccination planning and long-term monitoring for patients with autoimmune skin diseases.
    Discuss this study in the Community →

    Research cited in this study

    9 / 9 results